Connect with us

BIOTECH

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Reports R&D Management Appointments

Published

on

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) reported the engagement of Volker Knappertz, M.D. as its Chief Medical Officer. Reporting to company’s CEO Justin Gover, the new CMO will be based in the firm’s U.S. headquarters in California. In addition, the company reported that Professor Ben Whalley will be the new Head of Discovery Research, and he will be based in the U.K.

The details

The CEO of GW Pharmaceutical reported that he is thrilled to welcome Knappertz and Whalley to company in these major R&D roles. Knappertz has a remarkable record of new drug development and getting regulatory approvals which, with his extensive experience in neurology, makes him suited to lead company’s regulatory and clinical activities pertaining to Epidiolex® and their product pipeline. Additionally, Whalley’s leading position in the segment of Hemp science, especially pertaining to epilepsy, will be a major asset to company in the pursuit of their pipeline discovery programs.

Dr. Knappertz has clinical trial experience of over 25 years and pharmaceutical drug development experience of more than 17 years, holding leadership roles with responsibilities for managing global clinical study and medical affairs programs.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

Recently, as the VP of clinical advancement for multiple sclerosis, oncology and biosimilar offerings at Teva Pharmaceuticals, Dr. Knappertz managed multiple regulatory filings and approvals in the United States, Europe, Japan and Canada. Prior to his role with Teva, Dr. Knappertz served in medical and clinical roles in CNS, biologics and CV at AstraZeneca and Bayer Pharmaceuticals.

Dr. Knappertz is a U.S. Board approved neurologist who obtained his residency training at Yale University, where he worked as chief resident and was trained at Wake Forest University. On his new role, Dr. Knappertz reported that he is extremely thrilled about the prospect to continue the work of offering regulatory approved Hemp-based pharmaceutical drugs to patients with unmet medical needs.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         

TRENDING STORIES

INDUSTRIAL HEMP5 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...

INDUSTRIAL HEMP5 months ago

Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...

INDUSTRIAL HEMP5 months ago

Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....

INDUSTRIAL HEMP5 months ago

Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...

INDUSTRIAL HEMP5 months ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...

INDUSTRIAL HEMP5 months ago

Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...

INDUSTRIAL HEMP5 months ago

CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...

INDUSTRIAL HEMP5 months ago

Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...

INDUSTRIAL HEMP5 months ago

Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...

INDUSTRIAL HEMP5 months ago

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...

Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play